New recommendations that urge policymakers to protect patients’ access to evidence-based treatment, remove barriers to comprehensive pain care.
American Medical Association
2015 AMA Opioid Task Force recommendations
The original recommendations from the AMA Opioid Task Force provide six ways for physicians to take action to end the epidemic.
What does a sufficient pain care formulary look like?
The AMA believes it is essential for formularies to also include a broad range of evidence-based pain care options. This resource is meant to provide an overview for policymakers of the types of treatments practicing physicians use to treat pain but may be subject to formulary exclusion or administrative barriers such as prior authorization or step therapy, or subject to cost-prohibitive co-pays, cost sharing and adverse formulary tiering.
AMA Fact Sheet: PDMP use increases from 61 million to 462 million from 2014-2018
AMA Opioid Task Force: Snapshot of organizations’ efforts
This document provides a snapshot of some of the work being done by the member organizations of the AMA Opioid Task Force.